MedTrace Logo

The Utility of Next-generation Sequencing for the Diagnosis of Periprosthetic Joint Infection

NCT03200470 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2017-10-12

No results posted yet for this study

Summary

This is a prospective multicenter study. All patients presenting for revision hip or knee arthroplasty for all indications under the respective surgeon's care may be eligible. Per standard of care preoperatively, all patients must have blood drawn for erythrocyte sedimentation rate(ESR), C-reactive protein(CRP) and D-dimer. Aspiration of the joint in question may be performed at the discretion of the treating surgeon and results documented. Intraoperative samples will also be collected and sent for NGS analysis

Conditions

  • Prosthetic Joint Infection

Interventions

OTHER

No intervention: sample collection study

Sample collection and collection of laboratory values

Sponsors & Collaborators

  • Rothman Institute Orthopaedics

    lead OTHER

Principal Investigators

  • Tiffany Morrison, MS, CCRP · Rothman Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-16
Primary Completion
2018-02-28
Completion
2018-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03200470 on ClinicalTrials.gov